Enalare Therapeutics
EVP of Hikma Pharmaceuticals leading US Injectable Division
SVP Allergan (Actavis) – Head of Business Development, Portfolio & Business Intelligence, Global Generic Medicines
SVP Teva, Global Business Development
Executive positions with top tier companies including Johnson & Johnson and Novartis
MBA Johnson College of Business, Cornell University
MS Engineering, Cornell
Enalare Therapeutics
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.